Squarepoint
PLXP

Squarepoint’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Squarepoint’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,307
Closed -$199K – 3643
2021
Q3 		$199K Buy
+10,307
New +$180K ﹤0.01% 2492

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

Squarepoint's PLXP Position: Q4 2021 in Review

Squarepoint sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2021, closing a stake of 10,307 shares — an estimated $199K sold.

Squarepoint first reported a position in PLXP in Q3 2021 and held it in 1 quarter. The position peaked at $199K in Q3 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • Squarepoint reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Squarepoint sold 10,307 PLx Pharma Inc. Common Stock shares in Q4 2021, an estimated $199K.
  • Squarepoint first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Squarepoint's PLx Pharma Inc. Common Stock position peaked at $199K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.